{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:58:06Z","timestamp":1794272286131,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Galala University","id":[{"id":"https:\/\/ror.org\/04x3ne739","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to assess the prevalence and risk factors associated with late xerostomia and hyposalivation in head and neck cancer (HNC) patients after radiotherapy (RT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>An observational, multicentric cross-sectional study was conducted on 260 HNC patients attending various radiation centers for follow up 1-year post-treatment. Clinical assessments included the Subjective Dry Mouth Score (SXI), Clinical Oral Dryness Score (CODS), and Unstimulated Salivary Flow Rate (UWS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Xerostomia was reported by 78% of patients, with higher severity in those over 50 years (Mean\u2009\u00b1\u2009SD: 13.53\u2009\u00b1\u20091.09). Women showed lower salivary flow (UWS:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.556,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and higher xerostomia scores (SXI:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.337, CODS:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.359) than men. Tumor site correlated strongly with xerostomia (SXI:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.894,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), with oral cavity tumors showing more severe effects than nasopharyngeal tumors. Higher RT dose and fraction were negatively associated with UWS (\n                      <jats:italic>r<\/jats:italic>\n                      = -0.537,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and positively correlated with SXI (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.293) and CODS (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.405,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The regression models showed that xerostomia severity is significantly predicted by advanced tumor stage, female gender, older age, and higher radiation dose exposure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study reveals a high prevalence of xerostomia and hyposalivation among HNC survivors. Increased xerostomia severity and decreased salivary flow were significantly associated with advanced tumor stage, higher radiation doses, and concurrent chemoradiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>Understanding risk factors can guide early interventions and personalized management to enhance long-term oral health outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-025-02737-1","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:28:05Z","timestamp":1762504085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prevalence of late xerostomia and hyposalivation with associated risk factors in survivors of head and neck cancer after radiotherapy: a multi-centric cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-8257","authenticated-orcid":false,"given":"Asmaa","family":"Abou-Bakr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma E. A.","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"3","key":"2737_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2737_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2737_CR3","first-page":"51","volume":"67","author":"KD Shield","year":"2017","unstructured":"Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, Soerjomataram I. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67(1):51\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2737_CR4","doi-asserted-by":"publisher","first-page":"2432222","DOI":"10.1080\/20565623.2024.2432222","volume":"11","author":"D Ghalwash","year":"2025","unstructured":"Ghalwash D, Ammar A, Abou-Bakr A, Diab AH, El-Gawish A. Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population. Future Sci OA. 2025;11(1):2432222.","journal-title":"Future Sci OA"},{"issue":"19","key":"2737_CR5","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.3390\/cancers13194912","volume":"13","author":"G Anderson","year":"2021","unstructured":"Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A. An updated review on head and neck cancer treatment with radiation therapy. Cancers. 2021;13(19):4912.","journal-title":"Cancers"},{"issue":"1","key":"2737_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/s12903-025-06391-7","volume":"25","author":"A Abou-Bakr","year":"2025","unstructured":"Abou-Bakr A, Ahmed E, William H, Hassanein FEA. Frequency of periodontal disease in head and neck cancer patients after radiation therapy: a cross-sectional study. BMC Oral Health. 2025;25(1):1008.","journal-title":"BMC Oral Health"},{"issue":"7","key":"2737_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00432-025-06213-x","volume":"151","author":"FEA Hassanein","year":"2025","unstructured":"Hassanein FEA, Mikhail C, Elkot S, Abou-Bakr A. L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial. J Cancer Res Clin Oncol. 2025;151(7):198.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"2737_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE. Radiation therapy-associated toxicity: Etiology, management, and prevention. Cancer J Clin. 2021;71(5):437\u201354.","journal-title":"Cancer J Clin"},{"key":"2737_CR9","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1590\/1807-3107bor-2017.vol31.0014","volume":"31","author":"S Niklander","year":"2017","unstructured":"Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life. Braz Oral Res. 2017;31:e14.","journal-title":"Braz Oral Res"},{"key":"2737_CR10","doi-asserted-by":"crossref","unstructured":"Ibrahim SS, Hassanein FEA, Zaky HW, Gamal H. Clinical and biochemical assessment of the effect of glutamine in management of radiation induced oral mucositis in patients with head and neck cancer: randomized controlled clinical trial. J Stomatology Oral Maxillofacial Surg. 2024;125(3, Supplement):101827.","DOI":"10.1016\/j.jormas.2024.101827"},{"issue":"2","key":"2737_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/ijdr.IJDR_802_20","volume":"34","author":"AA Ras","year":"2023","unstructured":"Ras AA, Kheir El Din NH, Talaat AM, Hussein RR, Khalil E. Mucocutaneous changes in end-stage renal disease under regular hemodialysis - a cross-sectional study. Indian J Dent Res. 2023;34(2):130\u20135.","journal-title":"Indian J Dent Res"},{"issue":"12","key":"2737_CR12","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1002\/cam4.1221","volume":"6","author":"HY Sroussi","year":"2017","unstructured":"Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med. 2017;6(12):2918\u201331.","journal-title":"Cancer Med"},{"key":"2737_CR13","doi-asserted-by":"publisher","first-page":"3002034","DOI":"10.1155\/2023\/3002034","volume":"2023","author":"RR Hussein","year":"2023","unstructured":"Hussein RR, Ahmed E, Abou-Bakr A, El-Gawish AA, Ras AE, Ghalwash DM. Oral changes in hospitalized COVID-19 patients: A Cross-Sectional multicentric study. Int J Dent. 2023;2023:3002034.","journal-title":"Int J Dent"},{"issue":"7","key":"2737_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00784-015-1488-2","volume":"19","author":"A Villa","year":"2015","unstructured":"Villa A, Wolff A, Aframian D, Vissink A, Ekstr\u00f6m J, Proctor G, McGowan R, Narayana N, Aliko A, Sia YW, et al. World workshop on oral medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment. Clin Oral Investig. 2015;19(7):1563\u201380.","journal-title":"Clin Oral Investig"},{"issue":"10","key":"2737_CR15","doi-asserted-by":"publisher","first-page":"300060524128929","DOI":"10.1177\/03000605241289292","volume":"52","author":"D Ghalwash","year":"2024","unstructured":"Ghalwash D, El-Gawish A, Ammar A, Hamdy A, Ghanem R, Ghanem M, Abou-Bakr A. Epidemiology of Sjogren\u2019s syndrome in a sample of the Egyptian population: a cross-sectional study. J Int Med Res. 2024;52(10):3000605241289292.","journal-title":"J Int Med Res"},{"key":"2737_CR16","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jdent.2018.08.010","volume":"80","author":"AM Lynge Pedersen","year":"2019","unstructured":"Lynge Pedersen AM, Belstr\u00f8m D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent. 2019;80:S3\u201312.","journal-title":"J Dent"},{"key":"2737_CR17","doi-asserted-by":"crossref","unstructured":"Stolze J, Teepen JC, Raber-Durlacher JE, Loonen JJ, Kok JL, Tissing WJE, de Vries ACH, Neggers S, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM et al. Prevalence and risk factors for hyposalivation and Xerostomia in childhood cancer survivors following different treatment Modalities-A Dutch childhood cancer survivor study late effects 2 clinical study (DCCSS LATER 2). Cancers (Basel) 2022;14(14).","DOI":"10.3390\/cancers14143379"},{"key":"2737_CR18","doi-asserted-by":"crossref","unstructured":"Hassanein FEA, El Barbary A, Hussein RR, Ahmed Y, El-Guindy J, Sarhan S, Abou-Bakr A. Diagnostic performance of ChatGPT-4o and DeepSeek-3 differential diagnosis of complex oral lesions: A multimodal imaging and case difficulty analysis. Oral Dis 2025.","DOI":"10.1111\/odi.70007"},{"issue":"1","key":"2737_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s43163-024-00614-4","volume":"40","author":"D Ghalwash","year":"2024","unstructured":"Ghalwash D, Abou-Bakr A, Hussein RR, El-Gawish AA. Comorbidities and final outcome of post COVID-19 associated oral mucormycosis patients: a cross-sectional study. Egypt J Otolaryngol. 2024;40(1):51.","journal-title":"Egypt J Otolaryngol"},{"key":"2737_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2334\/josnusd.17-0164","volume":"60","author":"S Niklander","year":"2018","unstructured":"Niklander S, Fuentes F, Sanchez D, Araya V, Chiappini G, Martinez R. Impact of 1% malic acid spray on the oral health-related quality of life of patients with Xerostomia. J Oral Sci. 2018;60:278\u201384.","journal-title":"J Oral Sci"},{"issue":"2","key":"2737_CR21","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.4317\/jced.57924","volume":"13","author":"C Mar\u00edn","year":"2021","unstructured":"Mar\u00edn C, D\u00edaz-de-Vald\u00e9s L, Conejeros C, Mart\u00ednez R, Niklander S. Interventions for the treatment of xerostomia: A randomized controlled clinical trial. J Clin Exp Dent. 2021;13(2):e104\u201311.","journal-title":"J Clin Exp Dent"},{"issue":"23","key":"2737_CR22","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1002\/cncr.33849","volume":"127","author":"P Aggarwal","year":"2021","unstructured":"Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Lu C, Goepfert RP, Fuller CD, Lai SY, Gunn GB, Chambers MS, et al. Determinants of patient-reported Xerostomia among long-term oropharyngeal cancer survivors. Cancer. 2021;127(23):4470\u201380.","journal-title":"Cancer"},{"issue":"21","key":"2737_CR23","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.3390\/app132111758","volume":"13","author":"J Frigaard","year":"2023","unstructured":"Frigaard J, Hynne H, Jensen JL. Development and proposal of a novel scoring system to classify dry mouth severity. Appl Sci. 2023;13(21):11758.","journal-title":"Appl Sci"},{"key":"2737_CR24","doi-asserted-by":"crossref","unstructured":"Challacombe SJ, Osailan SM, Proctor GB. Clinical Scoring Scales for Assessment of Dry Mouth. In: Carpenter G. Berlin, editor. Dry Mouth: A Clinical Guide on Causes, Effects and Treatments. edn. Heidelberg: Springer Berlin Heidelberg 2015: 119\u2013132.","DOI":"10.1007\/978-3-642-55154-3_8"},{"issue":"4","key":"2737_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10266-018-0339-4","volume":"106","author":"DHJ Jager","year":"2018","unstructured":"Jager DHJ, Bots CP, Forouzanfar T, Brand HS. Clinical oral dryness score: evaluation of a new screening method for oral dryness. Odontology. 2018;106(4):439\u201344.","journal-title":"Odontology"},{"issue":"1","key":"2737_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s40001-023-01351-9","volume":"28","author":"SS Ibrahim","year":"2023","unstructured":"Ibrahim SS, Abou-Bakr A, Ghalwash DM, Hussein RR. Effectiveness of thyme honey in the management of Xerostomia in geriatric patients with end-stage renal disease: a randomized controlled clinical trial with a biochemical assessment. Eur J Med Res. 2023;28(1):406.","journal-title":"Eur J Med Res"},{"issue":"1","key":"2737_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12903-025-06125-9","volume":"25","author":"D Ghalwash","year":"2025","unstructured":"Ghalwash D, El-Gawish A, Abou-Bakr A. Efficacy of Manuka honey oral rinse in treatment of Xerostomia among elderly patients: a randomized controlled trial. BMC Oral Health. 2025;25(1):777.","journal-title":"BMC Oral Health"},{"issue":"7","key":"2737_CR28","doi-asserted-by":"publisher","first-page":"e209072","DOI":"10.1001\/jamanetworkopen.2020.9072","volume":"3","author":"ER Gritz","year":"2020","unstructured":"Gritz ER, Talluri R, Fokom Domgue J, Tami-Maury I, Shete S. Smoking behaviors in survivors of Smoking-Related and Non-Smoking-Related cancers. JAMA Netw Open. 2020;3(7):e209072.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2737_CR29","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u2013386.","journal-title":"Int J Cancer"},{"key":"2737_CR30","first-page":"1039","volume":"18","author":"S Jensen","year":"2010","unstructured":"Jensen S, Pedersen A, Vissink A, Andersen E, Brown C, Davies A, Dutilh J, Fulton J, Jankovic L, Lopes N. A systematic review of salivary gland hypofunction and Xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18:1039\u201360.","journal-title":"Support Care Cancer"},{"issue":"6","key":"2737_CR31","doi-asserted-by":"publisher","first-page":"e850","DOI":"10.4317\/medoral.26823","volume":"29","author":"E Benito-Ramal","year":"2024","unstructured":"Benito-Ramal E, Camacho-Mourelo A, Gonz\u00e1lez-Navarro B, L\u00f3pez JL, Jan\u00e9-Salas E. Prevalence and risk factors of chronic oral complications in head and neck cancer therapies: A retrospective study. Med Oral Patol Oral Cir Bucal. 2024;29(6):e850\u20136.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2737_CR32","doi-asserted-by":"publisher","first-page":"100177","DOI":"10.1016\/j.oor.2024.100177","volume":"10","author":"DM abo el Fadel","year":"2024","unstructured":"abo el Fadel DM, Kamal Y, Hassouna AH, Ali A. Prevalence of oral side effects associated with chemo and radiotherapy in head and neck cancer treatment: A cross-sectional study in Egypt. Oral Oncol Rep. 2024;10:100177.","journal-title":"Oral Oncol Rep"},{"key":"2737_CR33","doi-asserted-by":"crossref","unstructured":"Schulz R, Bonzanini L, Ortigara G, Soldera E, Danesi C, Antoniazzi R, Ferrazzo K. Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy. J Appl Oral Sci 2021;29.","DOI":"10.1590\/1678-7757-2020-0854"},{"key":"2737_CR34","doi-asserted-by":"crossref","unstructured":"Martinez A, Silva I, Couto SB, Gandra R, Rosa E, Johann A, Souza PC. Late oral complications caused by head and neck radiotherapy: clinical and laboratory study. J Oral Maxillofacial Res 2020;11.","DOI":"10.5037\/jomr.2020.11303"},{"issue":"4","key":"2737_CR35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10103-017-2180-3","volume":"32","author":"LF Palma","year":"2017","unstructured":"Palma LF, Gonnelli FAS, Marcucci M, Dias RS, Giordani AJ, Segreto RA, Segreto HRC. Impact of low-level laser therapy on hyposalivation, salivary pH, and quality of life in head and neck cancer patients post-radiotherapy. Lasers Med Sci. 2017;32(4):827\u201332.","journal-title":"Lasers Med Sci"},{"issue":"5","key":"2737_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hed.26063","volume":"42","author":"EB Soldera","year":"2020","unstructured":"Soldera EB, Ortigara GB, Bonzanini LIL, Schulz RE, Danesi CC, Antoniazzi RP, Linhares Ferrazzo K. Clinical and sociodemographic factors associated with oral health-related quality of life in survivors of head and neck cancer. Head Neck. 2020;42(5):886\u201397.","journal-title":"Head Neck"},{"key":"2737_CR37","doi-asserted-by":"crossref","unstructured":"Cruvinel P, Pereira R, Fressatti A, Motta B, Motta A, Oliveira H, Ricz H, Macedo L, Tirapelli C. Cross-sectional study of 1-to-5- year head and neck cancer survivors. Brazilian J Oncol 2022;18.","DOI":"10.5935\/2526-8732.20220316"},{"issue":"12","key":"2737_CR38","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1002\/lary.27224","volume":"128","author":"I Likhterov","year":"2018","unstructured":"Likhterov I, Ru M, Ganz C, Urken ML, Chai R, Okay D, Liu J, Stewart R, Culliney B, Palacios D, et al. Objective and subjective hyposalivation after treatment for head and neck cancer: Long-term outcomes. Laryngoscope. 2018;128(12):2732\u20139.","journal-title":"Laryngoscope"},{"issue":"2","key":"2737_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/tobaccocontrol-2011-050294","volume":"21","author":"M Thun","year":"2012","unstructured":"Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96\u2013101.","journal-title":"Tob Control"},{"issue":"3","key":"2737_CR40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.soc.2015.03.001","volume":"24","author":"EM Rettig","year":"2015","unstructured":"Rettig EM, D\u2019Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24(3):379\u201396.","journal-title":"Surg Oncol Clin N Am"},{"key":"2737_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15446\/av.enferm.v38n2.83297","volume":"38","author":"C Mendon\u00e7a de Moraes","year":"2020","unstructured":"das Chagas Paiva EM, Mendon\u00e7a de Moraes C, Pereira de Brito TR, Braga Lima D. Coelho Leite Fava SM, do nascimento MC: perfil Dos atendimentos oncol\u00f3gicos de Uma macrorregi\u00e3o de sa\u00fade Brasileira. Av En Enfermer\u00eda. 2020;38:149\u201358.","journal-title":"Av En Enfermer\u00eda"},{"issue":"3","key":"2737_CR42","doi-asserted-by":"publisher","first-page":"155798832110163","DOI":"10.1177\/15579883211016361","volume":"15","author":"MS Lipsky","year":"2021","unstructured":"Lipsky MS, Su S, Crespo CJ, Hung M. Men and oral health: A review of sex and gender differences. Am J Mens Health. 2021;15(3):15579883211016361.","journal-title":"Am J Mens Health"},{"issue":"2","key":"2737_CR43","first-page":"148","volume":"19","author":"MB Visacri","year":"2015","unstructured":"Visacri MB, Ferrari GB, Pimentel R, Ambrosio RD, Lima CS, Mazzola PG, Moriel P. Evaluation of the quality of life of patients before treatment of squamous cell carcinoma of the head and neck by means of chemoradiotherapy. Contemp Oncol (Pozn). 2015;19(2):148\u201353.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"6","key":"2737_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.oooo.2018.07.055","volume":"126","author":"NB de Melo","year":"2018","unstructured":"de Melo NB, Bernardino IM, de Melo DP, Gomes DQC, Bento PM. Head and neck cancer, quality of life, and determinant factors: a novel approach using decision tree analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126(6):486\u201393.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2737_CR45","doi-asserted-by":"crossref","unstructured":"Vigstad S, Clancy A. Palliative patients get greater relief from early screening of symptoms and implementation of measures. Sykepleien Forskning 2019.","DOI":"10.4220\/Sykepleienf.2018.74591en"},{"key":"2737_CR46","doi-asserted-by":"crossref","unstructured":"Schulz RE, Bonzanini LIL, Ortigara GB, Soldera EB, Danesi CC, Antoniazzi RP, Ferrazzo KL. Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy. J Appl Oral Sci 2021.","DOI":"10.1590\/1678-7757-2020-0854"},{"key":"2737_CR47","doi-asserted-by":"publisher","first-page":"e20200854","DOI":"10.1590\/1678-7757-2020-0854","volume":"29","author":"RE Schulz","year":"2021","unstructured":"Schulz RE, Bonzanini LIL, Ortigara GB, Soldera EB, Danesi CC, Antoniazzi RP, Ferrazzo KL. Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy. J Appl Oral Sci. 2021;29:e20200854.","journal-title":"J Appl Oral Sci"},{"issue":"5","key":"2737_CR48","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.21873\/anticanres.15743","volume":"42","author":"B Warwas","year":"2022","unstructured":"Warwas B, Cremers F, Gerull K, Leichtle A, Bruchhage KL, Hakim SG, Schild SE, Rades D. Risk factors for Xerostomia following radiotherapy of Head-and-Neck cancers. Anticancer Res. 2022;42(5):2657\u201363.","journal-title":"Anticancer Res"},{"issue":"1","key":"2737_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clon.2015.09.002","volume":"28","author":"T Gupta","year":"2016","unstructured":"Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP. Systematic review and Meta-analysis of conventionally fractionated concurrent chemoradiotherapy versus altered fractionation radiotherapy alone in the definitive management of locoregionally advanced head and neck squamous cell carcinoma. Clin Oncol (R Coll Radiol). 2016;28(1):50\u201361.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"2737_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.20892\/j.issn.2095-3941.2016.0096","volume":"14","author":"S Minhas","year":"2017","unstructured":"Minhas S, Kashif M, Altaf W, Afzal N, Nagi AH. Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma. Cancer Biol Med. 2017;14(2):176\u201382.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"2737_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12957-024-03456-9","volume":"22","author":"Y Shen","year":"2024","unstructured":"Shen Y, Shan J. Chemoradiotherapy versus radiotherapy in high risk salivary gland cancer. World J Surg Oncol. 2024;22(1):181.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"2737_CR52","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1590\/0103-6440201802302","volume":"29","author":"BA Agostini","year":"2018","unstructured":"Agostini BA, Cericato GO, Silveira ERD, Nascimento GG, Costa FDS, Thomson WM, Demarco FF. How common is dry mouth? Systematic review and Meta-Regression analysis of prevalence estimates. Braz Dent J. 2018;29(6):606\u201318.","journal-title":"Braz Dent J"},{"key":"2737_CR53","first-page":"35","volume":"71","author":"A dos Santos Menezes","year":"2014","unstructured":"dos Santos Menezes A, Rosmaninho \u00c9, Raposo B, Alencar M. Abordagem cl\u00ednica e terap\u00eautica Da mucosite oral Induzida Por radioterapia e Quimioterapia Em Pacientes com c\u00e2ncer. Revistas. 2014;71:35.","journal-title":"Revistas"},{"issue":"suppl 4","key":"2737_CR54","doi-asserted-by":"publisher","first-page":"e20190785","DOI":"10.1590\/0034-7167-2019-0785","volume":"73","author":"VL Pinto","year":"2020","unstructured":"Pinto VL, Fustinoni SM, Naz\u00e1rio ACP, Facina G, Elias S. Prevalence of Xerostomia in women during breast cancer chemotherapy. Rev Bras Enferm. 2020;73(suppl 4):e20190785.","journal-title":"Rev Bras Enferm"},{"issue":"8","key":"2737_CR55","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/odi.12710","volume":"23","author":"RV Lalla","year":"2017","unstructured":"Lalla RV, Treister N, Sollecito T, Schmidt B, Patton LL, Mohammadi K, Hodges JS, Brennan MT. OraRad study G: oral complications at 6 months after radiation therapy for head and neck cancer. Oral Dis. 2017;23(8):1134\u201343.","journal-title":"Oral Dis"},{"key":"2737_CR56","doi-asserted-by":"crossref","unstructured":"Jensen SB, Vissink A, Limesand KH, Reyland ME. Salivary gland hypofunction and Xerostomia in head and neck radiation patients. J Natl Cancer Inst Monogr 2019, 2019(53).","DOI":"10.1093\/jncimonographs\/lgz016"},{"issue":"4","key":"2737_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jcms.2017.01.020","volume":"45","author":"AA Owosho","year":"2017","unstructured":"Owosho AA, Thor M, Oh JH, Riaz N, Tsai CJ, Rosenberg H, Varthis S, Yom SH, Huryn JM, Lee NY, et al. The role of Parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. J Craniomaxillofac Surg. 2017;45(4):595\u2013600.","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02737-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:03:02Z","timestamp":1762509782000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2737"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02737-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was conducted in compliance with the ethical principles of the Helsinki Declaration for medical research involving human subjects, as revised in 2013, and follows the guidelines applicable to observational, cross-sectional studies. The study protocol was reviewed and approved by the Ahmed Maher Hospital research ethics committee (HAM00221). All eligible individuals provided with written informed consent to participate in the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}